You are here
Featured Video Play Icon Video 

InvestorIntel Interviews Dr. Zerbe of IntelGenx on Cialis deal

InvestorIntel Interviews Dr. Zerbe of IntelGenx on Cialis deal

InvestorIntel Interviews Dr. Zerbe of IntelGenx on Cialis deal

In this InvestorIntel interview, Dr. Horst G. Zerbe, President and CEO of IntelGenx Technologies Corp. (TSXV: IGX |OTCQX: IGXT), discusses the recent deal with Eli Lilly to manufacture Tadalafil (also known as Cialis®) as a pharmaceutical oral film, using IntelGenx’s VersaFilm™ technology. IntelGenx’s tadalafil oral film offers an improved discrete dosage form that does not require water intake. Dr. Zerbe states that this deal is significant because moving forward potential partner licensees will not face any litigation after completing a deal with IntelGenx, making the launch and commercialization of a VersaFilm™ partnered product extremely easy.

 

Major Aerospace Stocks ( GOOG)   (MSFT ) ( AAPL ) (BBRY ) ( gopro )  ( WDC )




Click here for reuse options!
Copyright 2017 Investors Buz
follow me

Jadtecnic

Founder.Editor at Investors Buz
Richard Dambrosi (JADTECNIC)Has Been Sharing Forex Analysis Trending Markets News since 2011. Editors and Founder of InvestorsBuz.com , has a passion for Forex Social Sharing analysis and Market Trends Such as Self Driving Cars , Electric Cars, Medical Marijuana , 3d printing and Cloud computing , Refers to Readers as BUZ INVESTORS.
follow me
READ  Biogen Inc: Merck-Allergan Deal Could Send BIIB Stock Soaring

Leave a Comment